2-(n,n-dipropyl)amino-5,6-dihydroxytetralin has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dijkstra, D; Johnson, SJ; Meltzer, LT; Venhuis, BJ; Wikström, HV; Wise, LD; Wustrow, D | 1 |
1 other study(ies) available for 2-(n,n-dipropyl)amino-5,6-dihydroxytetralin and Disease Models, Animal
Article | Year |
---|---|
Orally active oxime derivatives of the dopaminergic prodrug 6-(N,N-di-n-propylamino)-3,4,5,6,7,8-hexahydro-2H-naphthalen-1-one. Synthesis and pharmacological activity.
Topics: Administration, Oral; Animals; Antiparkinson Agents; Cell Line; CHO Cells; Cricetinae; Disease Models, Animal; Dopamine Agents; Medial Forebrain Bundle; Motor Activity; Naphthalenes; Neurons; Oxidopamine; Oximes; Parkinson Disease; Prodrugs; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Recombinant Proteins; Stereoisomerism; Transfection | 2003 |